Articles by Patricia Van Arnum - BioPharm International

ADVERTISEMENT

ADVERTISEMENT

Articles by Patricia Van Arnum

US Government Awards $400 Million in Contracts for Vaccine Manufacturing

Novartis, GlaxoSmithKline, and Lonza are among those participating in newly formed consortiums for developing and producing medical countermeasures.
Jun 20, 2012

Novartis, GlaxoSmithKline, and Lonza are among those participating in newly formed consortiums for developing and producing medical countermeasures.

ISEP Issues Change-Management Guide

The new guide outlines potential product life-cycle approaches to the change-management system of a pharmaceutical quality system
Jun 5, 2012

The new guide outlines potential product life-cycle approaches to the change-management system of a pharmaceutical quality system.

GlaxoSmithKline Moves Forward with $2.6 Billion Offer for Human Genome Sciences

May 14, 2012

GlaxoSmithKline tenders offer of $13.00 per share in an unsolicited bid despite an earlier rejection by Human Genome Sciences.

Sanofi Gains Regulatory Approval for Expansion at Site in Ireland

May 7, 2012

The company receives FDA and EMA approval for expansion of fill and finish operations for alglucosidase alfa.

Watson Pharmaeuticals to Acquire Actavis for $5.6 Bilion

Apr 30, 2012

In a move designed to increase its international presence, Watson Pharmaceuticals has agreed to acquire Actavis for EUR 4.25 billion ($5.62 billion).

FDA Details Strategies for Addressing Globalization

A new report by FDA details the strategies, programs, and other activities the agency is using to address the rise of imported pharmaceutical products and APIs.
Apr 23, 2012

A new report by FDA details the strategies, programs, and other activities the agency is using to address the rise of imported pharmaceutical products and APIs.

US Spending on Prescription Drugs Increased Moderately in 2011

Apr 17, 2012

US spending on prescription drugs increased moderately in 2011 reflecting increased generic-drug incursion and lower spending on prescription drugs. Pfizer retained its number one position of the top company of US prescription drug sales, and the generic-drug company Teva Pharmaceutical moved into the top-five companies of US prescription drug sales.

GPhA Urges Congress to Move Ahead on Generic-Drug and Biosimilar User Fees

Apr 10, 2012

On Mar. 29, 2012, the Generic Pharmaceutical Association (GPhA) reiterated its call for Congress to move forward with user-fee proposals for generic drugs and biosimilar products.

US Spending on Prescription Drugs Increased Moderately in 2011

Generic-drug incursion and reduced demand contribute to modest gains.
Apr 10, 2012

Generic-drug incursion and reduced demand contribute to modest gains.

ADVERTISEMENT

ADVERTISEMENT

Click here